A Phase II, Randomized, Safety and Immunogenicity Study of a Re-Derived, Live-Attenuated Dengue Virus Vaccine in Healthy Adults

por Thomas, Stephen J., Eckels, Kenneth H., Carletti, Isabelle, De La Barrera, Rafael, Dessy, Francis, Fernandez, Stefan, Putnak, Robert, Toussaint, Jean-Francois, Sun, Wellington, Bauer, Kristen, Gibbons, Robert V., Innis, Bruce L.
Publicado 2013

Cell-mediated immune responses to different formulations of a live-attenuated tetravalent dengue vaccine candidate in subjects living in dengue endemic and non-endemic regions

por Moris, Philippe, Bauer, Kristen M., Currier, Jeffrey R., Friberg, Heather, Eckels, Kenneth H., Esquilin, Ines O., Gibbons, Robert V., Innis, Bruce L., Jarman, Richard G., Simasathien, Sriluck, Sun, Peifang, Thomas, Stephen J., Watanaveeradej, Veerachai
Publicado 2019

Safety and Immunogenicity of a Dengue Virus Serotype-1 Purified-Inactivated Vaccine: Results of a Phase 1 Clinical Trial

por Martinez, Luis Javier, Lin, Leyi, Blaylock, Jason M., Lyons, Arthur G., Bauer, Kristen M., De La Barrera, Rafael, Simmons, Monika, Jarman, Richard G., Currier, Jeffrey R., Friberg, Heather, Danko, Janine R., Teneza-Mora, Nimfa C., Putnak, J. Robert, Eckels, Kenneth H., Thomas, Stephen J.
Publicado 2015

A Phase II, Randomized, Safety and Immunogenicity Trial of a Re-Derived, Live-Attenuated Dengue Virus Vaccine in Healthy Children and Adults Living in Puerto Rico

por Bauer, Kristen, Esquilin, Ines O., Cornier, Alberto Santiago, Thomas, Stephen J., Quintero del Rio, Ana I., Bertran-Pasarell, Jorge, Morales Ramirez, Javier O., Diaz, Clemente, Carlo, Simon, Eckels, Kenneth H., Tournay, Elodie, Toussaint, Jean-Francois, De La Barrera, Rafael, Fernandez, Stefan, Lyons, Arthur, Sun, Wellington, Innis, Bruce L.
Publicado 2015